Troglitazone (TROE-glit-a-zone) is used to treat a certain type of diabetes
mellitus (sugar diabetes) called type 2 diabetes. It may be used with insulin,
or with a type of oral diabetes medicine called a sulfonylurea, or with a
sulfonylurea and metformin.
This medicine was withdrawn from the U.S. market in March 2000.